Skip to main content
. 2021 Mar 24;8:629874. doi: 10.3389/fmolb.2021.629874

FIGURE 2.

FIGURE 2

Inhibitors of lipid-related pathways (bisindolylmaleimide-I, d-pantethine, glyburide, indomethacin, simvastatin, imipramine, GW4869, cambinol, and spiroepoxide) inhibit EV biogenesis.